These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 4753749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Reflections on the role of prevention in coronary cardiopathies].
    Blackburn H, Jeanneret O.
    Rev Med Suisse Romande; 1972 Mar; 92(3):171-80. PubMed ID: 5042659
    [No Abstract] [Full Text] [Related]

  • 3. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
    Bots ML, Grobbee DE.
    J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
    [Abstract] [Full Text] [Related]

  • 4. [Why the cardiologists should be interested in lipids?].
    López-Sendón JL, Rubio R, López de Sá E, Delcán JL.
    Rev Esp Cardiol; 1995 Jun; 48 Suppl 2():23-32. PubMed ID: 7569272
    [Abstract] [Full Text] [Related]

  • 5. Final results of the Helsinki Dietary Prevention Study.
    Karvonen MJ.
    Prog Food Nutr Sci; 1980 Jun; 4(5):27-32. PubMed ID: 7455144
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Certain problems of the organization of control of ischemic (coronary) heart disease].
    Il'inskiĭ BV.
    Klin Med (Mosk); 1974 Jun; 52(8):141-4. PubMed ID: 4424420
    [No Abstract] [Full Text] [Related]

  • 10. Importance of risk factor clustering in coronary heart disease mortality and incidence in eastern Finland.
    Jousilahti P, Toumilehto J, Vartiainen E, Korhonen HJ, Pitkäniemi J, Nissinen A, Puska P.
    J Cardiovasc Risk; 1995 Feb; 2(1):63-70. PubMed ID: 7606643
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H, Strandberg TE, Tikkanen I, Kauhanen P, Lepäntalo M.
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Choice and use of blood lipid tests. An epidemiologic perspective.
    Hulley SB, Lo B.
    Arch Intern Med; 1983 Apr; 143(4):667-73. PubMed ID: 6340621
    [Abstract] [Full Text] [Related]

  • 14. Health knowledge and community prevention of coronary heart disease.
    Puska P, Vienola P, Kottke TE, Salonen JT, Neittaanmäki L.
    Int J Health Educ; 1981 Apr; 24(2 Suppl):1-11. PubMed ID: 7257612
    [No Abstract] [Full Text] [Related]

  • 15. Rationale for use of lipid-lowering drugs.
    Dayton S.
    Fed Proc; 1971 Apr; 30(3):849-56. PubMed ID: 5575297
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of coronary heart disease.
    World Health Organ Tech Rep Ser; 1982 Apr; 678():1-53. PubMed ID: 6812294
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.